ARCHIVES

Zevalin Regimen Effective In Mantle Cell Lymphoma

This article is from The Cancer Letter archive.

Vol. 27 No. 1 | January 30, 2004

Download PDF Visit The Full Archive

Related Articles

NCI Programs: 15 New Grants Awarded In Survivor Research

October 9, 1998

$25 Million In Federal Aid to Jackson Laboratory approved By Senate; NIH, Natcher Are Opposed

August 11, 1989

Low Prevalence Of Tamoxifen Use For Cancer Prevention

February 26, 2010

Tobacco Control Bill Requires Stronger Warnings

August 10, 1990

Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer

July 26, 2002

Competition For Center Grants Higher In FY95, Kimes Tells BSC

November 25, 1994